0.7553

4.61% 0.0333

Pharmacyte Biotech Inc (PMCB)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Pharmacyte Biotech Inc stock is traded at $0.7553, with a volume of 74,296. It is up +4.61% in the last 24 hours and up +9.57% over the past month. PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

Previous Close:

$0.722

Open:

$0.73

24h Volume:

74,296

Relative Volume:

0.52

Market Cap:

$8.11M

Revenue:

Net Income/Loss:

$-3.28M

P/E Ratio:

-0.7258

EPS:

-1.0406

Net Cash Flow:

$-4.80M

1W Performance:

+4.57%

1M Performance:

+9.57%

6M Performance:

-18.78%

1Y Performance:

-35.44%

1-Day Range:

$0.7242

$0.7607

1-Week Range:

$0.70

$0.78

52-Week Range:

$0.63

$1.51

Pharmacyte Biotech Inc Stock (PMCB) Company Profile

Name

Pharmacyte Biotech Inc

Sector

Healthcare (1113)

Industry

Biotechnology (622)

Phone

(917) 595.2850

Address

3960 HOWARD HUGHES PARKWAY, LAS VEGAS

Employee

Twitter

Next Earnings Date

2026-03-16

Latest SEC Filings

PMCB's Discussions on Twitter

Compare PMCB vs MOBBW, GOODO, SHMD, PSNYW, DWLD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PMCB	2.24	0	0	0	0	0.00
MOBBW Mobilicom Limited Warrants	2.26	3.00B	0	0	0	0.00
GOODO Gladstone Commercial Corporation	20.08	372.90M	0	0	0	0.00
SHMD Schmid Group N V	6.37	368.19M	52.15M	-21.46M	0	-0.4675
PSNYW Polestar Automotive Holding Uk	3.20	296.01M	2.07B	-1.42B	-1.37B	-0.6765
DWLD Davis Select Worldwide ETF	46.83	0	0	0	0	0.00

Pharmacyte Biotech Inc Stock (PMCB) Latest News

Apr 27, 2026

Aug Intraday: Is PharmaCyte Biotech Inc a good ESG investment2026 Short Interest & Accurate Trade Setup Notifications - baoquankhu1.vn

Apr 13, 2026

PharmaCyte Biotech Operating Margin | PMCB - MLQ.ai

Apr 13, 2026

EV Market: Should I invest in PharmaCyte Biotech Inc before earningsJobs Report & Weekly High Return Opportunities - baoquankhu1.vn

Apr 13, 2026

How liquid is PharmaCyte Biotech Inc stockPortfolio Performance Report & High Accuracy Swing Entry Alerts - baoquankhu1.vn

Apr 13, 2026

Is PharmaCyte Biotech (PMCB) Stock Near Support | Price at $0.69, Up 5.96%Open Stock Signal Network - Cổng thông tin điện tử tỉnh Lào Cai

Apr 13, 2026

Apr 11, 2026

Aug Ideas: What is the Moat Score of PharmaCyte Biotech Inc2026 EndofYear Setup & Daily Technical Stock Forecast Reports - baoquankhu1.vn

Apr 11, 2026

Apr 09, 2026

Is PharmaCyte Biotech Inc vulnerable to short sellersMarket Sentiment Report & Growth Focused Stock Pick Reports - baoquankhu1.vn

Apr 09, 2026

Apr 03, 2026

PharmaCyte Biotech Shareholders Approve Governance and Equity Actions - The Globe and Mail

Apr 03, 2026

Apr 02, 2026

Director Weinstein receives 119,170 stock options at PharmaCyte Biotech (PMCB) - Stock Titan

Apr 02, 2026

Director at PharmaCyte Biotech (PMCB) gets 119,170 options - Stock Titan

Apr 02, 2026

PharmaCyte Biotech (PMCB) director awarded 119,170 stock options at $0.67 - Stock Titan

Apr 02, 2026

PharmaCyte Biotech (PMCB) director receives 119,170 stock options at $0.67 - Stock Titan

Apr 02, 2026

PharmaCyte Biotech (PMCB) wins approval for reverse split range and 2M new plan shares - Stock Titan

Apr 02, 2026

Mar 27, 2026

PMCB Stock Chart | PHARMACYTE BIOTECH INC (NASDAQ:PMCB) - ChartMill

Mar 27, 2026

Mar 20, 2026

Insider Sell: How liquid is PharmaCyte Biotech Inc stock2026 Setups & Safe Entry Momentum Tips - baoquankhu1.vn

Mar 20, 2026

Mar 19, 2026